Table des matières

Cerebrospinal Fluid Rhinorrhea - 22/08/11

Doi : 10.1016/B978-0-323-05283-2.00055-0 
Martin J. Citardi, Samer Fakhri

Key Points

Cerebrospinal fluid rhinorrhea may be classified as traumatic (>90%) or nontraumatic (<10%). Approximately 80% of all traumatic leaks occur in the setting of accidental trauma, and the remaining traumatic leaks occur after neurosurgical and rhinologic procedures. Nontraumatic etiologies include neoplasms and hydrocephalus.
Idiopathic nontraumatic cerebrospinal fluid rhinorrhea has been linked with elevated intracranial pressure. Numerous studies have confirmed an association of this entity with both benign intracranial hypertension and empty sella syndrome.
Clinical presentation includes unilateral watery drainage with a characteristic metallic or salty taste, often in the clinical setting of possible etiologic factors.
The differential diagnosis for watery rhinorrhea includes allergic rhinitis, vasomotor rhinitis, and retained nasal saline irrigation fluid as well as cerebrospinal fluid otorrhea that is draining through the eustachian tube.
Confirmation of a cerebrospinal fluid leak can be achieved through detection of β2-transferrin or β-trace protein in nasal secretions.
Cisternogram studies provide diagnosis confirmation and localization information. Both CT cisternography and radionuclide cisternography require lumbar puncture for the administration of tracer agent, whereas MRI cisternography can be achieved solely through specific imaging protocols. Radionuclide cisternography has poor sensitivity and poor spatial resolution. Both CT cisternography and MRI cisternography offer much greater spatial resolution but still require the presence of a relatively large, active leak for reliable detection.
Endoscopic examination after the administration of intrathecal fluorescein can confirm the diagnosis of a cerebrospinal fluid leak and indicate its location. Dilute fluorescein must be used; serious neurologic sequelae have been reported after higher intrathecal doses of this agent.
Endoscopic repair has emerged as the preferred modality for most cases of cerebrospinal fluid rhinorrhea requiring operative repair. During endoscopic repair, the leak site is identified and then closed with autogenous graft materials (fascia, free bone graft, fat), allograft (acellular dermal allograft), and xenogeneic collagen dural substitutes, or a combination. A free mucosal graft is typically placed over these materials, and the reconstruction is secured with surgical sealant and resorbable and nonresorbable packing material.
The role of prophylactic antibiotics remains controversial. Some data suggest that antibiotics should be administered after detection of a cerebrospinal fluid leak, but the data are far from conclusive. Certainly, in the presence of active infection adjacent to the leak site, antibiotics are prudent.
Traumatic cerebrospinal fluid leaks are likely to resolve with conservative measures (lumbar drainage and bed rest); operative repair is reserved for those cases in which these measures fail or in which massive injury requires urgent formal operative exploration and repair.
Cerebrospinal fluid leak that is recognized at the time of surgery should be repaired during that procedure. Cerebrospinal fluid rhinorrhea that develops after surgery may be managed conservatively at first, but most cases require operative repair.
Nontraumatic cerebrospinal fluid rhinorrhea is unlikely to resolve spontaneously. After potential etiologic factors (brain tumor) have been excluded, operative repair is warranted.

Plan



© 2010  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Article précédent Article précédent
  • Management of the Frontal Sinuses
  • Nick S. Jones
| Article suivant Article suivant
  • Endoscopic Dacryocystorhinostomy
  • Erik Kent Weitzel, Peter-John Wormald

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L'accès au texte intégral de ce chapitre nécessite l'achat du livre ou l'achat du chapitre.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à ce produit ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.